Showing results (331-340 of 382) with videos related to

Sort By:
Pageof 39
Circulation Reports|January 12, 2026
Design and Framework of JROAD-DPC - A Japanese Nationwide Registry Linking Diagnosis Procedure Combination Data With Cardiovascular Quality MetricsTatsuhiro Shibata, Koshiro Kanaoka, Yoshitaka Iwanaga, et al.
Journal of Arrhythmia|August 27, 2025
The Japanese Catheter Ablation Registry (J-AB): Annual Report in 2023Kengo Kusano, Koichi Inoue, Koshiro Kanaoka, et al.
Heart and Vessels|July 5, 2022
Declines in serum uric acid level after catheter ablation of atrial fibrillationDaisetsu Aoyama, Hiroyasu Uzui, Takayuki Sekihara, et al.
Journal of Arrhythmia|November 26, 2025
The Japanese Lead Extraction Registry (J-LEX): Annual Report in 2024Masahiko Goya, Morio Shoda, Kengo Kusano, et al.
Journal of the American Heart Association|March 24, 2020
Preprocedural Troponin T Levels Predict the Improvement in the Left Ventricular Ejection Fraction After Catheter Ablation of Atrial Fibrillation/FlutterDaisetsu Aoyama, Shinsuke Miyazaki, Kanae Hasegawa, et al.
Journal of Epidemiology|January 23, 2018
An 18-Year Follow-up Survey of Dioxin Levels in Human Milk in JapanRyusuke Ae, Yosikazu Nakamura, Hiroshi Tada, et al.
Breast Cancer Research and Treatment|March 31, 2023
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)Kenichi Watanabe, Naoki Niikura, Yuichiro Kikawa, et al.
Heart and Vessels|April 3, 2021
Cardiac rehabilitation after catheter ablation of atrial fibrillation in patients with left ventricular dysfunctionDaisetsu Aoyama, Shinsuke Miyazaki, Kanae Hasegawa, et al.
Breast Cancer Research and Treatment|October 24, 2023
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancerTakayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, et al.
Breast (Edinburgh, Scotland)|April 30, 2026
Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trialNaruto Taira, Yutaka Yamamoto, Hiroji Iwata, et al.
Pageof 39